High complete response rate is associated with improved progression- free and overall survival in 104 patients with multiple myeloma, treated with tandem cycle high-dose melphalan and busulfan/Cytoxan, and maintenance interferon alpha-2 (IF) with, or without thalidomide (thal)

Journal article

Peer reviewed

Somlo G, Yamamoto N, Carter N, O Donnell M, Snyder D, Sahebi F, Kogut N, Rodriguez R, Parker P, Popplewell L, …

Vol.102(11), pp.985a-986a

2003

Abstract

clinical immunology medicine

hematologymedicine

1 Record Views

Title: High complete response rate is associated with improved progression- free and overall survival in 104 patients with multiple myeloma, treated with tandem cycle high-dose melphalan and busulfan/Cytoxan, and maintenance interferon alpha-2 (IF) with, or without thalidomide (thal)
Creators: Somlo G
Yamamoto N
Carter N
O Donnell M
Snyder D
Sahebi F
Kogut N
Rodriguez R
Parker P
Popplewell L
Krishnan A
Fung H
Stein A
Spielberger R
Schriber J
Alvarnas J
Chow W
Nademanee A
Jasmine Z
Stephen F
Alecia L. Sabartinelli Stein - UMMG Department of Anesthesiology
Publication Details: Vol.102(11), pp.985a-986a
Academic Unit: Miller School of Medicine; UMMG Department of Anesthesiology
Language: English
Resource Type: Journal article
Record Identifier: 991031725844102976